LY-2811376

DB13065InvestigationalSmall molecule

LY2811376 has been used in trials studying the basic science of Alzheimer's Disease.

Chemical structure of LY-2811376
Mechanism
Curator reviewed
Formula / weight
C15H14F2N4S · 320.36 g/mol (avg)
Code names
J3.079.793K · LY2811376

Resolves to

Compound
UNIIUR18YJ97SJCAS1194044-20-6ChEMBLCHEMBL2333941PubChem44251605
Structure
InChIKeyMJQMRGWYPNIERM-HNNXBMFYSA-NSMILESC[C@]1(CCSC(N)=N1)C1=CC(=C(F)C=C1F)C1=CN=CN=C1
Targets
P56817BACE1

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with LY-2811376, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In